Hangzhou AGS Medtech CoSHSE:688581 -0.89%87 EBITDA Margin % is 47.98% as of Mar. 2026, which is 4% above its 10-year median of 46.32. GuruFocus rates SHSE:688581 with a GF Score™ of 87/100 and a GF Value™ of ¥74.30 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Hangzhou AGS Medtech Co ranks better than 97.55% on this metric.
Hangzhou AGS Medtech Co (SHSE:688581) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hangzhou AGS Medtech Co EBITDA Margin % Related Terms
Hangzhou AGS Medtech Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688581 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Hangzhou AGS Medtech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou AGS Medtech Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hangzhou AGS Medtech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou AGS Medtech Co (SHSE:688581) has a EBITDA Margin % of 47.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hangzhou AGS Medtech Co and its competitors. This is near median its historical median of 46.32. According to the industry distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 2.5%.
Is Hangzhou AGS Medtech Co's EBITDA Margin % too high?
Hangzhou AGS Medtech Co's current EBITDA Margin % of 47.98% is near median its 10-year median of 46.32. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. Hangzhou AGS Medtech Co's value of 47.98% is 542.3% above this industry median. Based on the distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou AGS Medtech Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou AGS Medtech Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 815 companies for EBITDA Margin %. This places Hangzhou AGS Medtech Co in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.47. Hangzhou AGS Medtech Co's value of 47.98% is 542.3% above this benchmark. While the company's 10-year median is 46.32 vs. the industry median of 7.47, Hangzhou AGS Medtech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou AGS Medtech Co's current EBITDA Margin % of 47.98% is 542.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hangzhou AGS Medtech Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou AGS Medtech Co's current EBITDA Margin % is 47.98%, which is near median its own 10-year median of 46.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou AGS Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co (SHSE:688581) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥74.30, compared to a current price of ¥55.70 — trading 25% below its estimated fair value. The current EBITDA Margin % is 47.98%, which is near median its 10-year median of 46.32 and 542.3% above the Medical Devices & Instruments industry median of 7.47. Hangzhou AGS Medtech Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hangzhou AGS Medtech Co (SHSE:688581), the current EBITDA Margin % is 47.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued.
The current stock price of ¥55.70 is trading 25% below its estimated GF Value™ of ¥74.30.
GuruFocus considers Hangzhou AGS Medtech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688581:
EBITDA Margin %: 47.98% (near median its 10-year median of 46.32)
GF Value™: ¥74.30 vs. price of ¥55.70 (25% below fair value)
Industry Position: 542.3% above the Medical Devices & Instruments median (#20 of 815)
No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
87GF Score
Get the complete analysis for SHSE:688581
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688581 has been successfully added to your 
